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Background
In the last decade the incidence of Clostridium difficile
infection (CDI) in children is progressively increasing
and the pediatricians are faced with difficulties in the
therapeutic approach.
Methods
We performed a retrospective study that analyzed the
antibacterial treatment in CDI from the experience of a
Pediatric Gastroenterology Department – Grigore
Alexandrescu Clinical Children’s Emergency Hospital,
Bucharest. Cases were identified through enzyme
immunoassays for A toxin or for A and B toxin of
Clostridium difficile in the stool.
Results
Between January 1st 2005 and July 31st 2014, 52 patients
were diagnosed with CDI. A large number of cases (61%)
were diagnosed in the age group 1 to 4 years. The sex
ratio was M/F = 0.9/1. 36% of patients had community-
acquired CDI. In mild/moderate forms metronidazole was
administered as a first-line treatment in 32 (61%) cases
and proved efficient in 25/32 (78.1%) cases; vancomycin
was used and was efficient in 18 cases. In severe forms
(7.7%), the association of intravenous metronidazole and
oral vancomycin was the option of choice and this
approach cured all these cases. We report 11 patients with
recurrent CDI (21%); in these cases oral vancomycin was
efficient for the treatment of the recurrence. In 3 cases
with a second recurrence rifaximin was the chosen ther-
apy. Six out of 11 children with recurrent CDI had comor-
bidities (Hirschsprung disease, ulcerative colitis).
Conclusion
The majority of patients in the study group were 1 to
4 years aged children. One third of patients had
community-acquired CDI. We consider that the failure
rate for metronidazole treatment is small and thereby
metronidazole may be recommended for the treatment
of the first episode of mild/moderate CDI. The associa-
tion of intravenous metronidazole and oral vancomycin
remains the treatment of choice for severe cases.
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